Postdoc on glaucoma drug development
The eye disorder glaucoma is the leading cause of irreversible blindness worldwide. Last resort treatment is surgical intervention: glaucoma filtration surgery. The current project is a part of a large, public-private funded project aimed to set a new standard of glaucoma filtration surgery.
- P Debyelaan, Maastricht, Limburg
- Tijdelijk contract / Tijdelijke opdracht
- Uren per week:
- 30 - 32 uur
- € 2588 - € 4757 per maand
The eye disorder glaucoma is the leading cause of irreversible blindness worldwide. Last resort treatment is surgical intervention: glaucoma filtration surgery. The current project is a part of a large, public-private funded project aimed to set a new standard of glaucoma filtration surgery. We will develop a new, innovative filtration implant and a tailor-made, sustained medication regimen. To achieve this, a consortium was founded consisting of several departments of the University Maastricht, the TU/e and a number of (inter)national companies.
The postdoc will select and design the new medication regimen on the basis of in vitro bioassays and select an appropriate drug delivery system. In addition, you will supervise the animal experiments in which prototypes of implants and medication regimen will be tested. This work will be performed in a team of senior scientists, ophthalmologists, PhDs, and technicians.
- PhD degree in biochemistry, pharmacy or related field.
- Preferably, expertise in drug design and sustained drug delivery.
- Excellent communication skills since the team members have diverse backgrounds.
- A creative can-do mentality and team spirit.
- Preferably, experience with animal studies.
The terms of employment of Maastricht University are set out in the Collective Labour Agreement of Dutch Universities (CAO). Furthermore, local UM provisions also apply. For more information look at the website www.maastrichtuniversity.nl .
Successful candidates will be offered contracts on the appropriate scale of the CAO UM
For information please contact dr. Theo Gorgels, email@example.com